{"id":"https://openalex.org/W4310124893","doi":"https://doi.org/10.1182/blood-2022-166403","title":"Chemotherapy-Based Regimes Increase Karyotype Complexity of Del(11q) CLL Cells and Impact the Response to Subsequent Ibrutinib Treatment","display_name":"Chemotherapy-Based Regimes Increase Karyotype Complexity of Del(11q) CLL Cells and Impact the Response to Subsequent Ibrutinib Treatment","publication_year":2022,"publication_date":"2022-11-15","ids":{"openalex":"https://openalex.org/W4310124893","doi":"https://doi.org/10.1182/blood-2022-166403"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2022-166403","doi":"https://doi.org/10.1182/blood-2022-166403","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-166403","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022013234","display_name":"Miguel Quijada \u00c1lamo","orcid":"https://orcid.org/0000-0002-4831-4565","observed_orcids":["https://orcid.org/0000-0002-4831-4565"]},"institutions":[{"id":"https://openalex.org/I184999862","display_name":"Universidad de Salamanca","ror":"https://ror.org/02f40zc51","country_code":"ES","type":"education","lineage":["https://openalex.org/I184999862"]},{"id":"https://openalex.org/I4210134045","display_name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca","ror":"https://ror.org/03em6xj44","country_code":"ES","type":"facility","lineage":["https://openalex.org/I184999862","https://openalex.org/I4210099034","https://openalex.org/I4210134045"]},{"id":"https://openalex.org/I4210138819","display_name":"Centro de Investigaci\u00f3n del C\u00e1ncer","ror":"https://ror.org/04rxrdv16","country_code":"ES","type":"facility","lineage":["https://openalex.org/I134820265","https://openalex.org/I184999862","https://openalex.org/I4210138819"]},{"id":"https://openalex.org/I4388891778","display_name":"Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer de Salamanca","ror":"https://ror.org/043vr8e29","country_code":"ES","type":"facility","lineage":["https://openalex.org/I134820265","https://openalex.org/I184999862","https://openalex.org/I4388891778"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Miguel Quijada \u00c1lamo","raw_affiliation_strings":["1Department of Medicine, University Hospital of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, University of Salamanca, Salamanca, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medicine, University Hospital of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, University of Salamanca, Salamanca, Spain","institution_ids":["https://openalex.org/I184999862","https://openalex.org/I4210134045","https://openalex.org/I4210138819","https://openalex.org/I4388891778"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010336471","display_name":"Laura Z. Rassenti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura Z. Rassenti","raw_affiliation_strings":["2Moores Cancer Center, University of California, San Diego, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Moores Cancer Center, University of California, San Diego, La Jolla, CA","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081515833","display_name":"Emanuela M. Ghia","orcid":"https://orcid.org/0000-0002-6060-6106","observed_orcids":["https://orcid.org/0000-0002-6060-6106"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emanuela M. Ghia","raw_affiliation_strings":["3Center for Novel Therapeutics, Moores Cancer Center, University of California, San Diego, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Center for Novel Therapeutics, Moores Cancer Center, University of California, San Diego, La Jolla, CA","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Tuan Tran","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tuan Tran","raw_affiliation_strings":["3Center for Novel Therapeutics, Moores Cancer Center, University of California, San Diego, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Center for Novel Therapeutics, Moores Cancer Center, University of California, San Diego, La Jolla, CA","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054987059","display_name":"Monica Spydell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Monica Spydell","raw_affiliation_strings":["3Center for Novel Therapeutics, Moores Cancer Center, University of California, San Diego, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Center for Novel Therapeutics, Moores Cancer Center, University of California, San Diego, La Jolla, CA","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042069620","display_name":"Elsa Molina","orcid":"https://orcid.org/0000-0003-1603-5438","observed_orcids":["https://orcid.org/0000-0003-1603-5438"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4210089535","display_name":"Sanford Consortium for Regenerative Medicine","ror":"https://ror.org/00cemh325","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210089535"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elsa Molina","raw_affiliation_strings":["4Sanford Consortium for Regenerative Medicine, University of California, San Diego, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Sanford Consortium for Regenerative Medicine, University of California, San Diego, La Jolla, CA","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4210089535"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076806777","display_name":"Claudia P\u00e9rez Carretero","orcid":"https://orcid.org/0000-0002-2089-2742","observed_orcids":["https://orcid.org/0000-0002-2089-2742"]},"institutions":[{"id":"https://openalex.org/I184999862","display_name":"Universidad de Salamanca","ror":"https://ror.org/02f40zc51","country_code":"ES","type":"education","lineage":["https://openalex.org/I184999862"]},{"id":"https://openalex.org/I4210134045","display_name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca","ror":"https://ror.org/03em6xj44","country_code":"ES","type":"facility","lineage":["https://openalex.org/I184999862","https://openalex.org/I4210099034","https://openalex.org/I4210134045"]},{"id":"https://openalex.org/I4210138819","display_name":"Centro de Investigaci\u00f3n del C\u00e1ncer","ror":"https://ror.org/04rxrdv16","country_code":"ES","type":"facility","lineage":["https://openalex.org/I134820265","https://openalex.org/I184999862","https://openalex.org/I4210138819"]},{"id":"https://openalex.org/I4388891778","display_name":"Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer de Salamanca","ror":"https://ror.org/043vr8e29","country_code":"ES","type":"facility","lineage":["https://openalex.org/I134820265","https://openalex.org/I184999862","https://openalex.org/I4388891778"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Claudia P\u00e9rez Carretero","raw_affiliation_strings":["1Department of Medicine, University Hospital of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, University of Salamanca, Salamanca, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medicine, University Hospital of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, University of Salamanca, Salamanca, Spain","institution_ids":["https://openalex.org/I184999862","https://openalex.org/I4210134045","https://openalex.org/I4210138819","https://openalex.org/I4388891778"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004453681","display_name":"Luis Antonio Corchete","orcid":"https://orcid.org/0000-0003-4577-8599","observed_orcids":["https://orcid.org/0000-0003-4577-8599"]},"institutions":[{"id":"https://openalex.org/I184999862","display_name":"Universidad de Salamanca","ror":"https://ror.org/02f40zc51","country_code":"ES","type":"education","lineage":["https://openalex.org/I184999862"]},{"id":"https://openalex.org/I4210134045","display_name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca","ror":"https://ror.org/03em6xj44","country_code":"ES","type":"facility","lineage":["https://openalex.org/I184999862","https://openalex.org/I4210099034","https://openalex.org/I4210134045"]},{"id":"https://openalex.org/I4210138819","display_name":"Centro de Investigaci\u00f3n del C\u00e1ncer","ror":"https://ror.org/04rxrdv16","country_code":"ES","type":"facility","lineage":["https://openalex.org/I134820265","https://openalex.org/I184999862","https://openalex.org/I4210138819"]},{"id":"https://openalex.org/I4388891778","display_name":"Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer de Salamanca","ror":"https://ror.org/043vr8e29","country_code":"ES","type":"facility","lineage":["https://openalex.org/I134820265","https://openalex.org/I184999862","https://openalex.org/I4388891778"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Luis A. Corchete","raw_affiliation_strings":["1Department of Medicine, University Hospital of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, University of Salamanca, Salamanca, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medicine, University Hospital of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, University of Salamanca, Salamanca, Spain","institution_ids":["https://openalex.org/I184999862","https://openalex.org/I4210134045","https://openalex.org/I4210138819","https://openalex.org/I4388891778"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101842213","display_name":"Teresa Gonz\u00e1lez","orcid":"https://orcid.org/0000-0002-0930-0021","observed_orcids":["https://orcid.org/0000-0002-0930-0021"]},"institutions":[{"id":"https://openalex.org/I184999862","display_name":"Universidad de Salamanca","ror":"https://ror.org/02f40zc51","country_code":"ES","type":"education","lineage":["https://openalex.org/I184999862"]},{"id":"https://openalex.org/I4210134045","display_name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca","ror":"https://ror.org/03em6xj44","country_code":"ES","type":"facility","lineage":["https://openalex.org/I184999862","https://openalex.org/I4210099034","https://openalex.org/I4210134045"]},{"id":"https://openalex.org/I4210138819","display_name":"Centro de Investigaci\u00f3n del C\u00e1ncer","ror":"https://ror.org/04rxrdv16","country_code":"ES","type":"facility","lineage":["https://openalex.org/I134820265","https://openalex.org/I184999862","https://openalex.org/I4210138819"]},{"id":"https://openalex.org/I4388891778","display_name":"Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer de Salamanca","ror":"https://ror.org/043vr8e29","country_code":"ES","type":"facility","lineage":["https://openalex.org/I134820265","https://openalex.org/I184999862","https://openalex.org/I4388891778"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Teresa Gonz\u00e1lez","raw_affiliation_strings":["1Department of Medicine, University Hospital of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, University of Salamanca, Salamanca, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medicine, University Hospital of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, University of Salamanca, Salamanca, Spain","institution_ids":["https://openalex.org/I184999862","https://openalex.org/I4210134045","https://openalex.org/I4210138819","https://openalex.org/I4388891778"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035896968","display_name":"Jes\u00fas Mar\u00eda Hern\u00e1ndez\u2010Rivas","orcid":"https://orcid.org/0000-0002-9661-9371","observed_orcids":["https://orcid.org/0000-0002-9661-9371"]},"institutions":[{"id":"https://openalex.org/I184999862","display_name":"Universidad de Salamanca","ror":"https://ror.org/02f40zc51","country_code":"ES","type":"education","lineage":["https://openalex.org/I184999862"]},{"id":"https://openalex.org/I4210134045","display_name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca","ror":"https://ror.org/03em6xj44","country_code":"ES","type":"facility","lineage":["https://openalex.org/I184999862","https://openalex.org/I4210099034","https://openalex.org/I4210134045"]},{"id":"https://openalex.org/I4210138819","display_name":"Centro de Investigaci\u00f3n del C\u00e1ncer","ror":"https://ror.org/04rxrdv16","country_code":"ES","type":"facility","lineage":["https://openalex.org/I134820265","https://openalex.org/I184999862","https://openalex.org/I4210138819"]},{"id":"https://openalex.org/I4388891778","display_name":"Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer de Salamanca","ror":"https://ror.org/043vr8e29","country_code":"ES","type":"facility","lineage":["https://openalex.org/I134820265","https://openalex.org/I184999862","https://openalex.org/I4388891778"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jes\u00fas Mar\u00eda Hern\u00e1ndez-Rivas","raw_affiliation_strings":["1Department of Medicine, University Hospital of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, University of Salamanca, Salamanca, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medicine, University Hospital of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, University of Salamanca, Salamanca, Spain","institution_ids":["https://openalex.org/I184999862","https://openalex.org/I4210134045","https://openalex.org/I4210138819","https://openalex.org/I4388891778"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036828560","display_name":"Thomas J. Kipps","orcid":"https://orcid.org/0000-0002-0064-4549","observed_orcids":["https://orcid.org/0000-0002-0064-4549"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas J. Kipps","raw_affiliation_strings":["3Center for Novel Therapeutics, Moores Cancer Center, University of California, San Diego, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Center for Novel Therapeutics, Moores Cancer Center, University of California, San Diego, La Jolla, CA","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2500,"currency":"USD","value_usd":2500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.22747629,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"140","issue":"Supplement 1","first_page":"4113","last_page":"4114"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9950000047683716},{"id":"https://openalex.org/keywords/del-11q","display_name":"del(11q)","score":0.9679999947547913},{"id":"https://openalex.org/keywords/ibrutinib","display_name":"ibrutinib","score":0.9049999713897705},{"id":"https://openalex.org/keywords/chemotherapy","display_name":"chemotherapy","score":0.44600000977516174},{"id":"https://openalex.org/keywords/karyotype-complexity","display_name":"karyotype complexity","score":0.8199999928474426},{"id":"https://openalex.org/keywords/chromosomal-abnormalities","display_name":"chromosomal abnormalities","score":0.8500000238418579},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9290000200271606},{"id":"https://openalex.org/keywords/relapsed-refractory-cll","display_name":"relapsed/refractory CLL","score":0.8769999742507935},{"id":"https://openalex.org/keywords/microrna-expression-profiling","display_name":"miRNA expression profiling","score":0.5680000185966492},{"id":"https://openalex.org/keywords/next-generation-sequencing","display_name":"next-generation sequencing","score":0.5019999742507935},{"id":"https://openalex.org/keywords/treatment-response-biomarkers","display_name":"treatment response biomarkers","score":0.4309999942779541},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.6000000238418579},{"id":"https://openalex.org/keywords/treatment-naive-patients","display_name":"treatment-naive patients","score":0.4880000054836273},{"id":"https://openalex.org/keywords/bcl2l13","display_name":"BCL2L13","score":0.31200000643730164}],"concepts":[{"id":"https://openalex.org/C2779878957","wikidata":"https://www.wikidata.org/wiki/Q5984881","display_name":"Ibrutinib","level":4,"score":0.9533145427703857},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5482465028762817},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4919852912425995},{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.4912554621696472},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.4895661771297455},{"id":"https://openalex.org/C53226629","wikidata":"https://www.wikidata.org/wiki/Q189967","display_name":"Karyotype","level":4,"score":0.4809526801109314},{"id":"https://openalex.org/C90059517","wikidata":"https://www.wikidata.org/wiki/Q423572","display_name":"Bruton's tyrosine kinase","level":4,"score":0.47973838448524475},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4408486485481262},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.41932445764541626},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.39060091972351074},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3817972242832184},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.36090534925460815},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.3384408950805664},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.2063162922859192},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.19506767392158508},{"id":"https://openalex.org/C30481170","wikidata":"https://www.wikidata.org/wiki/Q37748","display_name":"Chromosome","level":3,"score":0.1328616738319397},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.10814017057418823},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.10144209861755371}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2022-166403","doi":"https://doi.org/10.1182/blood-2022-166403","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-166403","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2747656856","https://openalex.org/W2961471425","https://openalex.org/W2140052555","https://openalex.org/W2281809861","https://openalex.org/W2903922531","https://openalex.org/W2604070126","https://openalex.org/W2913229295","https://openalex.org/W2580953357","https://openalex.org/W2930854972","https://openalex.org/W204478610"],"abstract_inverted_index":{"The":[0],"introduction":[1],"of":[2,9,19,125,151,159,179,211,215,225,256,268,292,304,348,402,409,431,454,468,483,548,573,597,621,624,659,671,680,693],"targeted":[3],"agents":[4,474,554,667],"in":[5,41,52,64,189,252,279,321,345,411,435,465,485,508,538,580,585,610,618,655,699],"the":[6,16,46,104,174,177,180,183,222,245,253,280,290,302,346,352,399,407,428,480,544,576,619,656,676,691],"treatment":[7,168,420,439,491,525,664],"strategy":[8],"chronic":[10],"lymphocytic":[11],"leukemia":[12],"(CLL)":[13],"has":[14,29],"changed":[15],"prognostic":[17],"implications":[18],"some":[20],"traditional":[21],"high-risk":[22],"markers":[23],"such":[24,645],"as":[25,695],"del(11q).":[26],"Recent":[27],"data":[28,68,689],"suggested":[30],"that":[31,427,498,644],"this":[32,98,107,627],"alteration":[33],"might":[34],"associate":[35],"with":[36,45,76,118,130,338,351,421,472,526,552,588,593,614,665,675,685],"superior":[37],"progression-free":[38],"survival":[39],"(PFS)":[40],"patients":[42,147],"(pts)":[43],"treated":[44,75,117,129,471,551,613,684],"BTK":[47],"inhibitor":[48],"ibrutinib":[49,694],"(Ibr),":[50],"especially":[51],"treatment-na\u00efve":[53],"(TN)":[54],"cases":[55,80,195,237,437,487],"(Kipps":[56],"et":[57,94],"al.":[58,95],"2019).":[59],"This":[60],"seems":[61],"to":[62,67,102,162,170,176,260,300,363,382,504],"be":[63,649],"marked":[65],"contrast":[66],"from":[69,331,356,368,518,575],"chemotherapy":[70],"(CHT)":[71],"relapsed/refractory":[72],"(CHT-R/R)":[73],"pts":[74,116,128,166,181,205,218,228,259,273,307,336,359,371,447,521,541,550,612,683],"Ibr,":[77],"where":[78],"del(11q)":[79,114,190,193,204,226,257,269,305,332,357,369,374,387,403,436,486,509,519,540,549,578,586,611,636,639,657,661,672,681,700],"showed":[81,206],"inferior":[82],"PFS":[83,185,209,224,678],"than":[84,192,365,386],"CLLs":[85,470,641],"harboring":[86],"other":[87],"cytogenetic":[88],"abnormalities":[89],"(CAs)":[90],"(excluding":[91],"del(17p))":[92],"(Byrd":[93],"2020).":[96],"In":[97,220,288,463],"study":[99],"we":[100,326,405,425],"aimed":[101],"elucidate":[103],"mechanism":[105],"underlying":[106],"differential":[108,632,646],"response":[109,255],"between":[110,285,635],"TN":[111,191,203,217,270,333,358,637,682],"and":[112,145,265,271,282,334,343,424,477,523,569,638,642],"CHT-R/R":[113,146,194,227,236,258,272,306,335,370,376,389,640,660],"CLL":[115,127,329,413,510,520],"Ibr.":[119,261,349,686],"We":[120,239,512],"conducted":[121],"a":[122,149,207,250,466,589,594,696],"retrospective":[123],"analysis":[124,175],"211":[126],"Ibr-based":[131],"regimes":[132,423,500],"(n=88":[133],"TN;":[134],"n=123":[135],"CHT-R/R).":[136],"Median":[137],"follow-up":[138],"was":[139,186,229,298,433,605],"37":[140],"months":[141],"(mo)":[142],"[IQR":[143],"17-54]":[144],"had":[148],"median":[150,184,223],"3":[152],"therapies":[153],"[1-7]":[154],"(at":[155],"least":[156],"one":[157],"line":[158],"CHT)":[160],"prior":[161],"Ibr":[163,364,383,633],"start.":[164],"Thirty":[165],"discontinued":[167],"due":[169],"adverse":[171],"events.":[172],"Restricting":[173],"rest":[178],"(n=181),":[182],"significantly":[187],"longer":[188],"(not":[196],"reached":[197],"(NR)":[198],"vs":[199,213,231,311,314,442,460,494],"45":[200,230],"mo;":[201],"P=0.001).":[202],"5-year":[208],"rate":[210],"100%":[212],"75%":[214],"non-del(11q)":[216,235],"(P=0.1).":[219],"contrast,":[221,289],"54":[232],"mo":[233,310],"for":[234],"(P=0.45).":[238],"next":[240],"investigated":[241],"whether":[242],"differences":[243],"at":[244],"genomic":[246],"level":[247],"would":[248],"play":[249],"role":[251],"diminished":[254],"Targeted":[262],"next-generation":[263],"sequencing":[264],"miRNA":[266,283],"profiling":[267],"did":[274,448,555],"not":[275,449,556],"reveal":[276],"substantial":[277],"changes":[278,537],"mutational":[281],"profile":[284],"both":[286],"groups.":[287],"presence":[291,347,620],"complex":[293],"karyotype":[294,400,506,516,536,591,602,653],"(\u22653":[295],"CAs;":[296],"CK)":[297],"able":[299],"stratify":[301],"outcome":[303],"(median":[308],"31":[309],"NR":[312],"(CK":[313],"non-CK);":[315],"P=0.014).":[316],"To":[317,393],"validate":[318],"these":[319],"findings":[320],"an":[322,451],"ex":[323,384],"vivo":[324,385],"setting,":[325],"co-cultured":[327],"primary":[328,377],"cells":[330,341,355,367,378,390],"(n=18)":[337],"HS5":[339],"stromal":[340],"(+CpG":[342],"IL2)":[344],"Consistent":[350],"clinical":[353],"findings,":[354],"were":[360,379],"more":[361,380],"sensitive":[362],"those":[366],"(P=0.012).":[372],"Moreover,":[373,663],"CK":[375],"resistant":[381],"non-CK":[388],"(n=8;":[391],"P=0.05).":[392],"evaluate":[394],"how":[395],"CHT":[396,457,527,534],"could":[397,648],"impact":[398],"stability":[401,670],"pts,":[404],"quantified":[406],"number":[408,430,453,482],"CAs":[410,432,455,484,559],"263":[412],"samples":[414,517],"before":[415,522],"(n=85)":[416],"or":[417,529],"after":[418,438,456,490,524,560],"(n=178)":[419],"CHT-based":[422],"found":[426],"mean":[429,481],"higher":[434,590],"(mean":[440,458,492],"1.7":[441],"3.7;":[443],"P=0.01).":[444],"Importantly,":[445],"non-del(11q)/non-del(17p)":[446],"show":[450],"increased":[452],"1.1":[459],"1.0;":[461],"P=0.36).":[462],"parallel,":[464],"cohort":[467],"314":[469],"non-CHT":[473,499,530,553,615,666],"(n=175":[475],"pre-":[476],"n=139":[478],"post-therapy),":[479],"remained":[488],"stable":[489],"2.4":[493],"1.9;":[495],"P=0.1),":[496],"suggesting":[497],"are":[501],"less":[502,607],"prone":[503],"induce":[505],"instability":[507],"cells.":[511],"further":[513],"analyzed":[514],"longitudinal":[515],"(n=9)":[528],"(n=19)":[531],"agents.":[532],"Notably,":[533],"induced":[535],"6/9":[539],"(P=0.03),":[542],"whereas":[543],"vast":[545],"majority":[546],"(18/19)":[547],"acquire":[557],"additional":[558],"treatment.":[561],"Karyotype":[562],"clonal":[563,603,669],"evolution":[564,574,604],"analyses":[565],"revealed":[566],"linear":[567],"(3/6)":[568,571],"branched":[570],"patterns":[572],"founder":[577],"clone":[579,658],"post-CHT":[581],"samples,":[582],"all":[583],"resulting":[584],"clones":[587],"complexity,":[592],"particular":[595],"enrichment":[596],"chromosome":[598],"8":[599],"CAs.":[600],"Conversely,":[601],"far":[606],"frequent":[608],"(1/19)":[609],"agents,":[616],"even":[617],"multiple":[622],"lines":[623],"therapy.":[625],"Collectively,":[626],"work":[628],"uncovers":[629],"previously":[630],"unknown":[631],"sensitivity":[634,647],"shows":[643],"mediated":[650],"through":[651],"CHT-induced":[652],"complexity":[654],"pts.":[662],"maintains":[668],"cells,":[673],"consistent":[674],"prolonged":[677],"rates":[679],"Thus,":[687],"our":[688],"support":[690],"use":[692],"first-line":[697],"therapy":[698],"CLL.":[701]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-11-30T00:00:00"}